Ask AI
ProCE Banner Activity

Optimizing Bridging Therapy: Selection and Timing to Support CAR T-Cell Success in MM

Slideset

Downloadable slideset on the importance of bridging therapy in optimizing outcomes for patients with multiple myeloma receiving CAR T-cell therapy. Here, an expert reviews data from key clinical trials and real-world studies, highlighting how effective bridging therapy can improve patient safety, reduce the risk of early mortality, and enhance the efficacy of CAR T-cell therapy.

Released: October 30, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson